RGEN vs TECH: stock comparison and AI forecast
Repligen Corp (RGEN) and Bio-Techne Corp (TECH) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
RGEN Repligen Corp
- Price
- $173.49 +37.2% · 6M
- Market Cap
- $11.09B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
TECH Bio-Techne Corp
- Price
- $72.78 +43.0% · 6M
- Market Cap
- $11.43B
- P/E Ratio
- 66.2x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- RGEN and TECH have similar market capitalizations ($11.09B and $11.43B).
- Over the last six months TECH returned +43.0% and RGEN +37.2%.
- RGEN carries 0.40 times debt per unit of equity, against 0.22 times for TECH.
- TECH yields 0.44% in dividends; RGEN pays none.
- Both companies share the SEC industry classification Biological Products, (No Diagnostic Substances).
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | RGEN | TECH |
|---|---|---|
| Market Cap | $11.09B | $11.43B |
| P/E Ratio | – | 66.16x |
| P/B Ratio | 5.30x | 5.28x |
| Dividend Yield | – | 0.44% |
| EPS | $-0.08 | $1.10 |
| Book Value/Share | $32.72 | $13.79 |
| Revenue/Share | $12.60 | $7.82 |
| FCF/Share | $1.67 | $1.96 |
Profitability & Margins
| Metric | RGEN | TECH |
|---|---|---|
| ROE | – | 7.9% |
| ROA | – | 6.5% |
| ROIC | 0.7% | 10.6% |
| Gross Margin | 53.8% | 65.8% |
| Operating Margin | 2.3% | 19.6% |
| Net Margin | – | 14.0% |
| EBT Margin | 1.0% | 18.5% |
| Tax Rate | 243.4% | 24.4% |
Financial Health
| Metric | RGEN | TECH |
|---|---|---|
| Current Ratio | 9.88x | 2.28x |
| Quick Ratio | 8.43x | 1.74x |
| D/E Ratio | 0.40x | 0.22x |
| Financial Leverage | 1.40x | 1.22x |
| Interest Coverage | – | 13.8x |
| Working Capital | $1.12B | $464M |
Cash Flow
| Metric | RGEN | TECH |
|---|---|---|
| Operating Cash Flow | $130M | $338M |
| Free Cash Flow | $107M | $308M |
| Capital Spending | -$23M | -$29M |
| OCF Growth YoY | -0.8% | 34.4% |
| FCF Growth YoY | -3.0% | 37.5% |
| FCF/Sales | 13.2% | 25.1% |
| CapEx/Sales | 2.9% | 2.4% |
Operational Efficiency
| Metric | RGEN | TECH |
|---|---|---|
| Asset Turnover | 0.28x | 0.47x |
| Receivables Turnover | 5.3x | 6.0x |
| Inventory Turnover | 2.0x | 2.1x |
| Fixed Assets Turnover | 4.9x | 5.4x |
| Days Sales Outstanding | 69 days | 60 days |
| Days Inventory | 179 days | 172 days |
| Payables Period | 27 days | 27 days |
| Cash Conversion Cycle | 220 days | 205 days |
Income Statement
| Metric | RGEN | TECH |
|---|---|---|
| Total Revenue | $806M | $1.23B |
| Operating Income | $18M | $241M |
| Net Income | – | $172M |
| R&D Expense | $56M | $97M |
| SG&A Expense | $311M | $470M |
| Cost of Goods Sold | $372M | $421M |
Dividend & Shareholder Information
| Metric | RGEN | TECH |
|---|---|---|
| Dividends Per Share | – | $0.32 |
| Payout Ratio | – | 29.1% |
| Shares Outstanding | 64M | 157M |
| Net Income Growth | – | 120.5% |
| EPS Growth | – | 124.5% |
RGEN vs TECH: stock comparison and AI forecast
Which is bigger, RGEN or TECH?
RGEN and TECH have similar market capitalizations ($11.09B and $11.43B).
Which stock performed better over the last six months, RGEN or TECH?
Over the last six months TECH returned +43.0% and RGEN +37.2%.
Which one does Intratio's AI model rank higher, RGEN or TECH?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.